Ana Tadijan

10PUBLICATIONS
19CO-AUTHORS
Predictive and prognostic markersMedical molecular engineering of nucleic acids and proteinsMolecular targetsBiologically active moleculesCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jun 26, 2026
The p53 Isoforms as Potential Biomarkers in Different Cancer Entities.

|Sep 14, 2024
Mitochondrial NME6 Influences Basic Cellular Processes in Tumor Cells In Vitro.

Bastien Proust, Anđela Horvat, Ana Tadijan

|Jan 08, 2023
p53 Family in Resistance to Targeted Therapy of Melanoma.

Ignacija Vlašić, Anđela Horvat, Ana Tadijan

|Oct 27, 2022
Intracellular Molecular Targets and Signaling Pathways Involved in Antioxidative and Neuroprotective Effects of Cannabinoids in Neurodegenerative Conditions.

Ana Tadijan, Ignacija Vlašić, Josipa Vlainić

|Sep 09, 2022
Characterization of Vemurafenib-Resistant Melanoma Cell Lines Reveals Novel Hallmarks of Targeted Therapy Resistance.

Martina Radić, Ignacija Vlašić, Maja Jazvinšćak Jembrek

|Oct 23, 2021
Altered Expression of Shorter p53 Family Isoforms Can Impact Melanoma Aggressiveness.

Ana Tadijan, Francesca Precazzini, Nikolina Hanžić

Pageof 2

Frequent Collaborators

6 joint publications

Ignacija Vlašić

4 joint publications

Anđela Horvat

3 joint publications

Maja Jazvinšćak Jembrek

2 joint publications

Iva I Podgorski